TY - JOUR A1 - Hekmat, Khosro A1 - Salemink, B. A1 - Lauterbach, Gerhard A1 - Schwinger, R. H. G. A1 - Südkamp, M. A1 - Weber, Hans-Joachim A1 - Mehlhorn, U. T1 - Interference by cellular phones with permanent implanted pacemakers: an update JF - Europace. 6 (2004), H. 4 Y1 - 2004 SP - 363 EP - 369 ER - TY - JOUR A1 - Weber, Hans-Joachim A1 - Bhuju, S. A1 - Chandra, S. A1 - Mo, X. T1 - Fabrication of biodegradable nanofibers for tubular scaffolds in regenerative medicine / Weber, H.-J. ; Bhuju, S. ; Chandra, S. ; Mo, X. JF - Biomedizinische Technik. 49 (2004), H. Erg.-Bd. 2, Teil 2 Y1 - 2004 SP - 1016 EP - 1017 ER - TY - JOUR A1 - Weber, Hans-Joachim A1 - Laco, Filip A1 - Kun, Ma A1 - Ramakrishna, S. T1 - The dose effect of human bone marrow-derived mesenchymal stem cells on epidermal development in organotypic co-culture / Laco, Filip ; Kun, Ma ; Weber, Hans Joachim ; Ramakrishna, S. ; Chan, Casey K. JF - Journal of Dermatological Science. 55 (2009), H. 3 Y1 - 2009 SN - 0923-1811 SP - 150 EP - 160 ER - TY - JOUR A1 - Weber, Hans-Joachim A1 - Hekmat, K. A1 - Zimmermann, T. A1 - Kampe, S. T1 - Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial / Hekmat, K. ; Zimmermann, T. ; Kampe, S. ; Kasper, S. M. ; Weber, H. J. ; Geissler, H. J. ; Meh JF - Current Medical Research and Opinion. 20 (2004), H. 1 Y1 - 2004 SN - 0300-7995 SP - 121 EP - 126 ER - TY - JOUR A1 - Behnam, S. A1 - Becker, A. A1 - Weber, Hans-Joachim T1 - Clinical benefit and cost-efficiency of minimized perfusion circuits for extracorporeal circulation during cardiac surgery JF - Zeitschrift für Herz-, Thorax- und Gefäßchirurgie Y1 - 2011 SN - 0930-9225 N1 - Abstracts der 40. Internationalen Jahrestagung der DGfK und 3. Fokustagung Herz Kardiotechnik – Intensivmedizin – Herzchirurgie – Rhythmustherapie 11. bis 13. November 2011 in Weimar VL - 25 IS - 5 SP - 305 EP - 306 PB - Springer CY - Berlin ER - TY - CHAP A1 - Weber, Hans-Joachim T1 - Applied physics of compressible and incompressible fluids T2 - Critical care nephrology / [Hrsg.:] Claudio Ronco and Rinaldo Bellomo Y1 - 1998 SN - 978-94-010-6306-7 SP - 63 EP - 84 PB - Springer CY - Dordrecht ER - TY - CHAP A1 - Weber, Hans-Joachim A1 - Porschen, W. A1 - Dietzel, F. A1 - [u.a.], ED - Streffer, Christian T1 - In vivo analysis of the influence of combined hyperthermia and gamma irradiation on euoxic and hypoxic tumor cells T2 - Cancer therapy by hyperthermia and radiation : [proceedings of the 2. International Symposium on Cancer Therapy by Hyperthermia and Radiation, Essen, 2.-4.6.1977] Y1 - 1978 SN - 0-8067-1701-7 SN - 3-541-71701-7 SP - 276 EP - 277 PB - Urban and Schwarzenberg CY - Baltimore ; Munich [u.a.] ER - TY - JOUR A1 - Porschen, W. A1 - Gartzen, J. A1 - Gewehr, K. A1 - Mühlensiepen, H. A1 - Weber, Hans-Joachim A1 - [u.a.], T1 - In vivo assay of the radiation sensitivity of hypoxic tumour cells : influence of γ-rays, cyclotron neutrons, misonidazole, hyperthermia and mixed modalities JF - The British journal of cancer / Supplement N2 - Tumour cell death can be evaluated in the living mouse by externally measuring the rate of loss of tumour-bound DNA tracer. By sequentially labelling the tumour-bearing animals with ¹²⁵IUdR and ¹³¹IUdR 50 h apart, the average tumour cells at the time of the second injection are labelled by ¹²⁵IUdR and the euoxic tumour cells are specifically labelled with ¹³¹IUdR. Tumour treatment at this stage of labelling permits the observation of the reaction of euoxic cells and average tumour cells and finally yields data on hypoxic cells and thus on the oxygen enhancement ratio. This information adds to results from tumour control and growth delay. With this technique effects were analysed of 60-Co γ-rays, cyclotron neutrons (E = 6 MeV), misonidazole (500 mg/kg body wt) and hyperthermia (42°C water-bath), or combinations of these. Misonidazole (15 min before irradiation) altered the oxygen enhancement ratio by a factor of 1·5 for γ-rays and of 1·1 for neutrons; when evaluated from tumour-growth delay and TCD-50 misonidazole gave a dose modifying factor of 1·47 for γ-rays and of 1·2-1·3 for neutrons. Based on percentage tumour regression 100 days after treatment, the enhancement ratio from hyperthermia (after irradiation) was 2·75 for γ-rays (at 10 Gray) and 2·2 for neutrons (at 3·2 Gray). For neutrons combined with misonidazole and hyperthermia the ratio was 2·4. These results demonstrate that effects of neutron irradiation may be modified by electron-affinic substances and/or hyperthermia. Y1 - 1978 SN - 0306-9443 N1 - Section 6: Sensitization and Hypoxic Cytotoxicity: Effects of Hyperthermia and High Let IS - 3 SP - 194 EP - 197 PB - Lewis CY - London ER - TY - JOUR A1 - Bleilevens, Christian A1 - Hill, Aileen A1 - Grzanna, Tim A1 - Fechter, Tamara A1 - Bohnen, Melanie A1 - Weber, Hans-Joachim A1 - Beckers, Christian A1 - Borosch, Sebastian A1 - Zayat, Rashad A1 - Benstoem, Carin A1 - Rossaint, Rolf A1 - Goetzenich, Andreas T1 - In vitro head-to-head comparison of anticoagulation properties of two heparin brands in a human blood miniature mock loop JF - Interactive cardiovascular and thoracic surgery Y1 - 2019 U6 - http://dx.doi.org/10.1093/icvts/ivy206 SN - 1569-9285 VL - 28 IS - 1 SP - 120 EP - 127 ER -